What is the DURYSTA™ Implant and how does it work?
DURYSTA™ is an innovative, sustained-release ocular implant that works to continuously deliver the medication Bimatoprost in the eye, in order to decrease and preserve healthy eye pressure. The nearly microscopic implant is pre-filled with 10 mcg of Bimatoprost medication, which is then injected into the eye. Once the implantation procedure—which takes no more than 5 to 10 minutes—is completed, the implant will continuously release the correct dosage of medication until it is all finished, usually within 4 to 6 months. There is no need for a separate procedure to remove the implant—since DURYSTA™ is biodegradable, it naturally breaks down and is safely removed by the body over time.
Am I a good candidate for DURYSTA™?
DURYSTA™ is a safe and very effective treatment option for people with open-angle glaucoma (OAG) and ocular hypertension (OHT).
DURYSTA™ is not recommended for those who:
- have an eye infection or are susceptible to getting one
- have undergone a corneal transplant
- have a damaged or missing posterior lens capsule
- suffer from corneal endothelial cell dystrophy
- are allergic to Bimatoprost or the implant materials